People · Operator
Named in public records as an officer, director or promoter · active 2017–2017 · Pharma, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pear Therapeutics, Inc. | — | Pharma | Series D+ | $254.8M | $4.1B | 2017 |
| Establishment Labs Holdings Inc. | — | Software / Tech | Series C | $56.3M | $540.1M | 2017 |
ANTOUN NABHAN at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside ANTOUN NABHAN on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Andrew Schwab | 1 | 16 |
| Timothy Petersen | 1 | 9 |
| Andrew J. Schwab | 1 | 7 |
| Rudy Mazzocchi | 1 | 6 |
| Dennis Condon | 1 | 5 |
| Corey McCann | 1 | 5 |
| Elena Viboch | 1 | 4 |
| Edward Schutter | 1 | 3 |
| Nick Lewin | 1 | 3 |
| David Hung | 1 | 3 |
| Nicholas Lewin | 1 | 2 |
| Allan Weinstein | 1 | 2 |
| Lisa Colleran | 1 | 2 |
| Alex Waldron | 1 | 2 |
| Zack Lynch | 1 | 2 |
| Zack J. Lynch | 1 | 1 |
| Tim J. Petersen | 1 | 1 |
| Bryan Slotkin | 1 | 1 |
| Leslie Gillin | 1 | 1 |
| Ross Mansbach | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.